Quantum Genomics (Quantum Genomics) Total Stockholders Equity : $3.86 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Total Stockholders Equity?

Quantum Genomics's Total Stockholders Equity for the quarter that ended in Dec. 2022 was $3.86 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Quantum Genomics's Book Value per Share for the quarter that ended in Dec. 2022 was $0.11. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Quantum Genomics's Debt-to-Equity for the quarter that ended in Dec. 2022 was 0.83.

Quantum Genomics Total Stockholders Equity Historical Data

The historical data trend for Quantum Genomics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Total Stockholders Equity Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

14.67

12.07

33.89

13.09

3.86

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Total Stockholders Equity	Get a 7-Day Free Trial															33.89	26.61	13.09	16.22	3.86

Quantum Genomics (OTCPK:QNNTF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Quantum Genomics's Book Value per Share for the quarter that ended in Dec. 2022 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.864	-	0)	/	34.7637
	=	0.11

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Quantum Genomics's Debt-to-Equity for the quarter that ended in Dec. 2022 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	3.214)	/	3.864
	=	0.83

Quantum Genomics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (Quantum Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ALQGC:France 2QG:Germany

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.